[Scleromyxedema as a systemic disease of glycosaminoglycan accumulation].

Autor:	Radenska-Lopovok SG; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia; Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia, Moscow, Russia., Volkova P; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Gorodetsky VR; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Egorova ON; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Ananyeva LP; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia.
Jazyk:	ruština
Zdroj:	Arkhiv patologii [Arkh Patol] 2018; Vol. 80 (3), pp. 53-58.
DOI:	10.17116/patol201880353-58
Abstrakt:	Scleromyxedema is a rare mucinosis with a primary skin lesion due to diffuse mucin deposition, sclerosis, and lichenoid eruptions in the absence of hypothyroidism. The paper describes scleromyxedema cases and gives recommendations for the histological diagnosis of the disease by histochemical reactions to detect acid and neutral glycosaminoglycans.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu